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Abstract
Background: Low back pain (LBP) remains a common health problem and one of the most prevalent
musculoskeletal conditions found among developed and developing nations. The following paper reports on an
updated search of the current literature into the prevalence of LBP among African nations and highlights the
specific challenges faced in retrieving epidemiological information in Africa.
Methods: A comprehensive search of all accessible bibliographic databases was conducted. Population-based
studies into the prevalence of LBP among children/adolescents and adults living in Africa were included.
Methodological quality of included studies was appraised using an adapted tool. Meta-analyses, subgroup analyses,
sensitivity analyses and publication bias were also conducted.
Results: Sixty-five studies were included in this review. The majority of the studies were conducted in Nigeria
(n = 31;47%) and South Africa (n = 16;25%). Forty-three included studies (66.2%) were found to be of higher
methodological quality. The pooled lifetime, annual and point prevalence of LBP in Africa was 47% (95% CI 37;58);
57% (95% CI 51;63) and 39% (95% CI 30;47), respectively.
Conclusion: This review found that the lifetime, annual and point prevalence of LBP among African nations was
considerably higher than or comparable to global LBP prevalence estimates reported. Due to the poor methodological
quality found among many of the included studies, the over-representation of affluent countries and the difficulty in
sourcing and retrieving potential African studies, it is recommended that future African LBP researchers conduct
methodologically robust studies and report their findings in accessible resources.
Trial registration: The original protocol of this systematic review was initially registered on PROSPERO with
registration number CRD42014010417 on 09 July 2014.
Keywords: Low back pain, Africa, Prevalence, Epidemiology, Systematic review, Meta-analysis
Background
Low back pain (LBP) is arguably the most prevalent
musculoskeletal condition found among both developed
and developing nations [1–4]. Broadly defined as pain or
discomfort in the lumbar region of the spine [1, 2]; LBP
is the leading cause of activity limitation, results in sig-
nificant losses in productivity at work and incurs billions
of dollars in medical expenditure annually [1, 3, 4]. The
prevalence of LBP worldwide is estimated to be between
30 and 80% among the general population and has been
found to increase with age [5]. In addition, a higher
prevalence of LBP has been associated with a lower
socioeconomic status and lower education levels [5, 6].
According to the Global Burden of Disease (GBD) 2010
study, LBP is currently the sixth highest burden on a list
of 291 conditions and is the cause of more years lived
with disability (YLDs) globally than any other disease
[4]. Affecting just about anyone, of any gender, race or
socioeconomic background [6], LBP has a substantial
impact on the overall and financial well-being of an
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individual and society [5, 7]. Therefore, it was postulated
that the burden of LBP would be greater in lower and
middle income countries (LMICs) like those situated in
Africa [7, 9]. A systematic review published in 2007 re-
vealed that the prevalence of LBP in Africa was
comparable to that of developing nations, and was
rising [10].
Despite the GBD 2010 and World Health Organization
(WHO) reports [4, 8, 9], and coupled with the high
prevalence of LBP in Africa [10]; LBP and other muscu-
loskeletal conditions remain less prioritized in LMICs,
due to more pressing health issues like HIV/AIDS [3].
This is most likely due to the fact that although LBP
causes significant disability and related health costs, it is
not life-threatening [4, 11]. LBP however remains a glo-
bal health concern and an immense burden for LMICs,
such as those in Africa where health budgets are already
restricted and channelled to other higher priority condi-
tions [1, 2, 5, 7]. Of concern is that due to various epide-
miologic challenges faced in various LMICs in Africa
and the subsequent lack of accurate data, the true bur-
den of LBP is still not well understood or known. In the
7 years since the previous review was published, a large
number of studies have emerged. The following paper
therefore reports on an updated search of the current lit-
erature into the prevalence of LBP among African na-
tions (children, adolescents, adults; males and females).
It was hoped that a better understanding of the current
burden of LBP in African LMICs would be established.
Furthermore, this paper also highlights the specific chal-
lenges faced in retrieving epidemiological information in
Africa and on conducting meta-analyses of LBP data, as
well as the methodological shortcomings of published
African studies.
Methods
The MOOSE (Meta-analysis Of Observational Studies
in Epidemiology) were used [12]. The protocol for this
updated review was registered on PROSPERO prior
to commencement (protocol registration number:
CRD42014010417) [13].
Studies had to primarily report on the prevalence of
LBP among nations situated on the African continent
were included. Studies could report on the prevalence of
musculoskeletal conditions as a whole, yet had to provide
subgroup data for LBP prevalence. Studies could report on
the following recall periods for LBP prevalence, namely:
point, annual or lifetime prevalence. Subjects included in
the studies could be any race, gender and age. Studies
could be published in English, Afrikaans or French, since
these are three of the most common languages in which
scholarly communication in Africa is conducted [14].
French studies were translated by a French-speaking Afri-
can native. To validate the translations, we cross-checked
the French translations with the English abstract of the
article (which is typically available online) to check for any
marked discrepancies and reverse translations were done
to ensure validity of translations. Dissertations, conference
proceedings, commentaries/letters and other grey litera-
ture were excluded from this review.
A comprehensive update of the previous search [10]
was conducted in the following bibliographic databases
via the Stellenbosch University’s library website: Ebsco-
Host (including CiNAHL, Africa-Wide Information,
Health Source: Nursing/Academic edition, SPORTDiscus)
, Medline, ScienceDirect, Scopus, PEDro, PubMed, SA
ePublications, Cochrane Library, ProQuest Medical
Library, African Journals Online (AJOL) and Web of
Science. The main search terms were: low back pain,
Africa and prevalence. The original search strategy was
revised where necessary and excluded management and
rehabilitation. The full search strategy is available on re-
quest from the corresponding author. Secondary search-
ing (PEARLing) was conducted (PEARLing is a search
method whereby the reference lists of all included and
excluded studies are searched for other studies which
may not have been identified during the database
search). Manual searching was not conducted due to the
difficulty in replicating this method. The search was
commenced and conducted between June 2014 and
October 2014, and an updated search was conducted in
March 2015 and July 2016. A final search was conducted
in April 2017, prior to submission. Articles published
and indexed from inception of the databases to the end
of the search period were included.
The titles and abstracts of all potentially relevant
population-based studies were screened by two re-
viewers independently. Methodological appraisal of in-
cluded studies was conducted using the same critical
appraisal tool as in the original review [10, 15]. The tool
was however further adapted for use in this review
(Table 1), by reducing the previous items 7, 8 and 9 to
one item (7a- c), as all these items pertained to the valid-
ation of the data collection tool used in the study. For
the purposes of this review, all items in the appraisal
tool were equally weighed and the total score for the
tool was 10. No subminimum criteria were applied.
Appraisal of studies was conducted independently by
two reviewers. Studies scoring 60% or less on the ap-
praisal tool were deemed as low quality studies and were
excluded from the meta-analyses. The 60% cut-off was
deemed appropriate based on the fact that no submini-
mum criteria were applied due to the heterogeneous
nature of LBP data and that the average methodological
score of all studies was 66%. It was therefore decided
that all studies which were below the average score were
relatively lower in methodological quality compared to
the rest of the included studies.
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Data were extracted using specifically-designed extrac-
tion sheets and were entered into Microsoft (MS) Excel
spreadsheets [16]. The following data were extracted from
included studies: author name(s), year of publication,
country of publication, study design, data collection tool/
outcome measure tool(s), population, study setting (includ-
ing if rural or urban setting), sample size, age group/age
(range and/or mean ± standard deviation), gender, data
collection period, LBP definition, LBP recall period,
reliability/validity of measurement tools, response rates
and LBP prevalence rates (point, annual and lifetime).
From the data extracted, the pooled point, annual and
lifetime prevalence (summary estimates) of LBP among
African nations, as well as the 95% confidence intervals
(CI), were calculated for conducting meta-analyses of
observational data. A random effects model to adjust for
heterogeneity was used since LBP data inherently varies
between studies due to differences in risk factors and
characteristics between populations. Sub-group analyses
were conducted for age group (adults and children/ado-
lescents), country status (low income, low middle in-
come and upper middle income), gender (male and
female) and setting (community, industry, hospital, pro-
fessional and school). Sensitivity analyses were con-
ducted to assess if the inclusion of the lower
methodological quality studies would change the results
of the analyses. Publication bias was also assessed using
Duval and Tweedie’s Trim and Fill method [81].
Results
The results of the comprehensive updated search of lit-
erature into the prevalence of LBP in Africa are depicted
in Fig. 1. A total of 65 studies were included in this re-
view (of which 40 were published after the original re-
view was conducted) [17–70, 81–91]. A list of the
excluded studies and the reasons for their exclusion is
available from the corresponding author.
General description of included studies
More than 72.3% of the included studies were con-
ducted in lower income and lower middle income
countries [17, 21, 22, 25–29, 31–34, 36, 37, 40–44,
46–48, 50–53, 57–60, 63–67, 69, 83–91]. The majority
of the studies were conducted in Nigeria, which is a lower
middle income country (n = 31; 47.7%) [22, 25, 27, 29, 32,
33, 36, 41, 44, 46–48, 50, 52, 53, 57–60, 64–66, 81–83,
86–91] and South Africa, which is an upper middle in-
come country (n = 16; 24.6%) [19, 20, 23, 24, 30, 35, 38,
39, 45, 49, 54–56, 61, 62, 70]. Three of the included stud-
ies were published in the French language [18, 26, 51], the
rest were published in English. Fifteen (27.8%) of the 54
independent African countries (countries as recognised by
the United Nations) are represented in this review. Forty-
five studies included both male and female participants
(75%) [17, 18, 20–22, 27–37, 40, 46, 48–53, 55, 57–59, 61,
62, 67–70, 81, 82, 84–86, 89, 90]. Fourteen of the included
studies included children and/or adolescents between the
ages 11 and 19 years (21.5%) [17–19, 31, 34, 35, 41, 44, 53,
56, 59, 67, 69, 85]. The response rates were reported by 72.
3% of the studies (n = 47) [19–25, 27, 28, 30–41, 46–50,
52–54, 59, 61–64, 66–70, 82, 85–91] and ranged from 11
to 100%. Forty-two of the studies were conducted in an
urban setting (64.6%), while nine studies (13.8%) where
Table 1 Methodological appraisal tool for LBP prevalence
studies (adapted) [15]
Criteria Yes/No Comments
Is the final sample representative of the target population?
1. At least 1 of the following must apply
in the study: an entire target
population, randomly selected sample
or sample stated to represent the
target population.
2. At least 1 of the following: reasons for
non-response described, non-responders
described, comparison of responders
and non-responders, or comparison of
sample and target population.
3. Response rate, and if applicable,
drop-out rate reported
Quality of data
4. Were the data primary data of LBP, or
was it taken from a survey not
specifically designed for that purpose?
5. Were the data collected from each
subject directly or were they collected
from a proxy?
6. Was the same mode of data collection
used for all subjects?
7. At least 1 of the following in case of:
a) Questionnaire: a validated
questionnaire or at least tested for
reproducibility?
b) Interview: interview validated, tested
for reproducibility, or adequately
described and standardized?
c) Examination: examination validated,
tested for reproducibility, adequately
described and standardized?
Definition of LBP
8. Was there a precise anatomic
delineation of the lumbar area or
reference to an easily obtainable article
that contains such specification?
9. Was there further useful specification of
the definition of LBP, or question(s) put
to study subjects quoted such as
frequency, duration, or intensity, and
character of the pain. Or was there
reference to an easily obtainable article
that contains such specification?
10. Were the recall periods clearly stated:
e.g. 1 week, 1 month, lifetime?
Total score (10)
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conducted in a rural setting. The rest of the studies (n = 14;
21.5%) were conducted in a setting which incorporated
both rural and urban communities.
The most common study design was cross-sectional
(n = 60; 92.3%). Two studies used a prospective study de-
sign [17, 42] and three used a retrospective study design
[21, 26, 84]. Most of the included studies used question-
naires. Three studies reviewed medical records [21, 26,
84], and eight studies included a physical examination [17,
40, 42–45, 47, 58]. Twelve studies conducted interviews
[17, 20, 40–44, 54, 55, 57, 58, 60]. It was unclear in three
of the studies which sampling method was used [19, 50,
59]. Nine studies did not explicitly provide a clear recall
period (point, lifetime or annual) for LBP (15%) [17, 41,
42, 44, 45, 49, 70, 71, 84]. Two studies used the index
pregnancy (up to 40 weeks) as the recall period [60, 83].
The most common population studied was health pro-
fessionals and hospital staff (n = 17; 26.2%) [22, 28, 30, 37,
45, 46, 48–52, 55, 61–63, 82, 91]. Health professions
studies included physiotherapists, general surgeons, den-
tists, nurses, general surgeons and oral hygienists.
Workers were studied in 21 of the eligible studies (32.3%)
[20, 24, 26, 27, 32, 33, 36, 38, 39, 43, 44, 47, 54, 57, 64–66,
81, 87–90] and included the following sectors: commer-
cial, industry, transport and farming. Computer-users
were only studied in one included study [36] and two
studies included sports players [19, 56]. The sports players
studied were cricketers. One study reported on LBP
Fig. 1 Flow chart depicting study selection procedure
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prevalence among school teachers [68]. An overview sum-
mary of the descriptive data extracted from the included
studies is provided in Table 2.
Methodological quality of included studies
Twenty-two (33.8%) of the included studies scored 60%
or less on the specified critical appraisal tool and were
therefore excluded from further analysis [17, 19, 21, 23,
26, 36, 38, 42, 44–46, 49–51, 55, 56, 58, 64, 83, 84, 86, 90].
Sixty-five percent (n = 42) of the included studies reported
on the validity and/or reliability of their data collection
tools (questionnaire, interview or examination) [31, 32, 34,
35, 39, 41–48, 50, 52–70, 81, 83, 85–91]. Only 24 of the
included studies (36.9%) provided a case definition for
LBP [18, 24, 25, 30–32, 34, 35, 37, 40, 41, 48, 52, 57,
65–69, 81, 83–85, 91]. Table 3 illustrates the meth-
odological appraisal of the included studies.
Lifetime, annual and point prevalence of LBP among
African nations
Lifetime, annual and point prevalence data of LBP
among African nations were calculated to provide a
summary estimate. Lifetime prevalence pertains to the
experience of LBP at any point in the individual’s life-
time; annual prevalence pertains to the experience of LBP
at any point in the past 6–12 months; and point preva-
lence pertains to the experience of LBP at the time of the
study’s data collection. For these purposes, only African
studies reporting a recall period of lifetime, annual or
point prevalence for LBP, were included for analyses.
 Lifetime prevalence of LBP in Africa
Sixteen studies reported on the lifetime prevalence of LBP
in Africa [18, 26, 30, 31, 34, 35, 37, 39, 64, 67, 70, 85, 86, 91].
The lifetime prevalence for LBP in Africa was estimated at
47% (95% CI 37;58). The summary analyses for lifetime
prevalence of LBP among Africans is depicted in Fig. 2.
Sensitivity and subgroup analyses were conducted to
ensure that the exclusion of the poorer methodological
quality studies would not have influenced the results
significantly if included. Figure 3 illustrates the sen-
sitivity and subgroup analyses conducted for lifetime
LBP prevalence among Africans. A significant difference
between the summary estimates calculated with only the
higher quality studies or only the lower quality studies,
compared to all studies (combined) was found.
 Annual prevalence of LBP in Africa
Thirty-four studies reported on the annual prevalence of
LBP in Africa [22, 25, 27–29, 32–34, 37, 39, 43, 46–54, 56,
57, 59, 61, 62, 65, 66, 68, 81, 82, 85–89]. The annual preva-
lence of LBP in Africa was estimated at 57% (95% CI 51;63).
The summary analyses for annual prevalence of LBP
among Africans is depicted in Fig. 4.
Figure 5 illustrates the sensitivity and subgroup ana-
lyses for annual LBP prevalence among African nations.
No significant differences between the summary esti-
mates calculated with only the higher quality studies or
only the lower quality studies, compared to all studies
(combined) were found.
 Point prevalence of LBP in Africa
Twenty-three studies reported on point prevalence of
LBP in Africa [17, 19–21, 23, 33, 39–42, 45, 54, 55, 58, 59,
63, 67, 69, 84–86, 91]. The point prevalence of LBP in
Africa was estimated at 39% (95% CI 30;47). The summary
analyses for point prevalence of LBP among Africans is
depicted in Fig. 6.
Figure 7 illustrates the subgroup and sensitivity analyses
for point LBP prevalence among Africans. No significant
differences between the summary estimates calculated with
only the higher quality studies or only the lower quality
studies, compared to all studies (combined) were found.
Publication bias
Duval and Tweedie’s “Trim and Fill” method was used
to assess publication bias [80]. Under the random effects
model the point estimate and 95% confidence interval
for the combined studies is 0.49 (95% CI 0.39, 0.57).
Using Trim and Fill the imputed point estimate is 0.31
(95% CI 0.24, 0.39). The method suggests that a total of
13 studies may be missing from this review.
Discussion
This paper provides an updated synthesis of the literature
into the prevalence of LBP among African populations.
The current review indicates that although a number of
years have passed after our initial review [10], LBP re-
mains a health concern in Africa.
Meta-analyses of the observational data collected from
the eligible studies provides a summary estimate of the
lifetime, annual and point prevalence. Lifetime, annual
and point prevalence of LBP among African populations
was found to be higher than recently reported estimates
for global LBP prevalence [2, 4, 5]. The global prevalence
of LBP reported by Hoy et al. in 2012 was calculated
from a total of 165 studies conducted in 54 countries
around the globe (developed and developing countries),
over a period of 29 years [2]. In our review, the point
prevalence of LBP among Africans was estimated at 39%
(95% CI 30;47), which is considerably higher than the
global LBP prevalence estimate (18.3%) reported by Hoy
et al. [2]. Similarly, the annual prevalence for LBP
among Africans (57%; 95% CI 51;63) found in our review
was substantially higher than the global annual LBP
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Table 3 Methodological appraisal of included studies (n = 65)
Criterion study ID 1 2 3 4 5 6 7 8 9 10 % MA
Mulimba [17] + – – + + + – – – – 40 No
Bezzaoucha [18] + – + + + + – + – + 70 Yes
Harris [19] – – + + + + – – + + 60 No
Schierhout et al. [20] + + + + + + – – – + 70 Yes
Mijiyawa et al. [21] – – – + – + – – – + 30 No
Omokhodion et al. [22] + – + + + + – – + + 70 Yes
Worku [23] + – + + – + – – + + 60 No
Wallner-Schlotfeldt et al. [24] – + + + + + – + + + 80 Yes
Omokhodion et al. [25] + + + + + + – + + + 90 Yes
Mbaye et al. [26] – – + + + + – – + + 60 No
Omokhodion et al. [27] + + + + + + – – – + 70 Yes
Igumbor et al. [28] + + + + + + – – + + 80 Yes
Omokhodion et al. [29] + + + + + + – – + + 80 Yes
Govender [30] + + + + + + – + + + 90 Yes
Prista et al. [31] + – + + + + + + + + 90 Yes
Fabunmi et al. [32] + – – + + + + + + + 80 Yes
Sanya et al. [33] + – + + + + – – + + 70 Yes
Bejia et al. [34] + + + + + + + + + + 100 Yes
Jordaan et al. [35] + + + + + + + + + + 100 Yes
Adedoyin et al. [36] – + + – + + – – + + 60 No
Bejia et al. [37] + + + + + + – + + + 90 Yes
Van Vuuren et al. [38] – – + + + + – – + + 60 No
Van Vuuren et al. [39] + + + + + + + – + + 90 Yes
Galukande et al. [40] – + + + + + – + + + 80 Yes
Ayanniyi et al. [41] + + + – + + + + + – 80 Yes
Hill et al. [42] + + – – + + + – – – 50 No
Bio et al. [43] + + – + + + + – + + 80 Yes
Balogun and Owoaje [44] + – – – + + + – – – 40 No
Naidoo and Coopoo [45] – + + + + + + – – – 60 No
Odebiyi et al. [87] – – + + + + + – + + 70 Yes
Adegoke et al. [46] + – + – + + + – – + 50 No
Akinbo et al. [47] + + – – + + + – + + 70 Yes
Sikiru and Shmaila [48] + – + + + + + + + + 90 Yes
Booysens et al. [49] + – + – + + – – + – 50 No
Isa et al. [82] + – – + – + + + + + 70 Yes
Tinubu et al. [50] – – + – + + + – – + 50 No
Ouédraogo et al. [51] – – – + + + – – – + 40 No
Sikiru and Hanifa [52] – – – + + + + + + + 70 Yes
Abiodun-Solanke et al. [83] + + – – + + – – + + 60 Yes
Ayanniyi et al. [53] + – + – + + + – + + 70 Yes
Saidu et al. [64] – – + – + + + – + – 50 No
Himalowa and Frantz [54] + + + + + + + – – + 80 Yes
Desai et al. [55] – – – – + + + – + + 50 No
Noorbhai et al. [56] + – – – + + + – + + 60 No
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prevalence (38.5%) reported by Hoy et al. [2]. The
lifetime prevalence for LBP among Africans (47%; 95%
CI 37;58) was also found to be considerably higher than
the estimates (38.9%) reported by Hoy et al. [2]. The
summary estimates found in this review were compared
specifically to North American and Western European
countries. It was found that the point LBP prevalence
among Africans was substantially higher than estimates
provided for Canada (28.7%), Denmark (12–13.7%) and
Sweden (23.2%), and was comparable to Germany (39.2)
and Belgium (33%) [5]. One year LBP prevalence among
Africans was considerably higher than Spain (20%), and
on par with Denmark (56%) and Ukraine (50.3%) [5].
The findings of this review therefore reiterates the fact
that LBP is a burden and is therefore a public health
concern among developing nations in Africa [4, 7, 8].
Despite the high burden, LBP remains a lower priority
compared to epidemics such as HIV/AIDS in Africa [3].
African healthcare budgets and systems may be generally
ill-prepared to deal with the management of LBP which
could partly explain the high LBP prevalence among Af-
rican populations [4, 9, 10, 71]. The successful develop-
ment and implementation of strategies and policies to
address the burden of LBP in poorer countries or
countries with emerging economies, like those in Africa,
is therefore warranted [9].
The lifetime, annual and point prevalence of LBP was
estimated to be higher among African adults compared
to African children and adolescents. This finding con-
firms that similarly to developed nations, the prevalence
of LBP among Africans increases with age [1, 2, 6].
These summary estimates for annual and lifetime LBP
prevalence among African children and adolescents were
however found to be higher than estimates reported for
the United Kingdom (15.6–24%), Finland (9.7%), and
Iran (15%), and comparable to Iceland (34%) and
Denmark (32.4%) [5], although point prevalence was
found to be lower or on par (11%). Of concern is that the
early onset of LBP in childhood or adolescents is a risk
factor for developing chronic LBP later in life [53, 72], and
once the younger generation become the working class,
the ongoing pain and related disability will ultimately
affect work productivity and the economy of a
country [1, 3, 53]. Therefore, in developing countries or
countries with emerging economies like African countries,
where budgets are already stringent [10], it would make
sense to implement effective prevention strategies to the
risk of developing LBP in childhood and/or adolescence,
Table 3 Methodological appraisal of included studies (n = 65) (Continued)
Criterion study ID 1 2 3 4 5 6 7 8 9 10 % MA
Birabi et al. [57] + – – + + + + + + + 80 Yes
Ogunbode et al. [58] + – – + + + + – – + 60 No
Oyeyemi et al. [84] – – – – + + + + + + 60 Yes
Akinpelu et al. [59] – – + + + + + – + + 70 Yes
Jimoh et al. [60] + + – + + + + – + + 80 Yes
Madiba et al. [61] + – + – + + + – + + 70 Yes
Tella et al. [65] – – – + + + + + + + 70 Yes
Rufa’i et al. [66] – + + + + + + + – + 80 Yes
Botha et al. [62] + – + – + + + – + + 70 Yes
El-Soud et al. [63] + + + + + + + – + – 80 Yes
Chiwaridzo et al. [67] + + + + + + + + + + 100 Yes
Erick and Smith [68] + + + + + + + + + + 100 Yes
Mwaka et al. [69] + – + – + + + + + – 70 Yes
Major-Helstoot et al. [70] + + + + + + + – – + 80 Yes
Akodu et al. [88] – – + + + + + – + + 70 Yes
Triki et al. [84] + – – + + + – + – – 50 No
Adegoke et al. [85] + – + + + + + + + + 90 Yes
Vincent-Onabajo et al. [86] – – + + + + + – – + 60 Yes
Akodu et al. [89] – – + + + + + – + + 70 Yes
Odebiyi et al. [90] + – + – + + + – – + 60 Yes
Belay et al. [91] + – + + + + + + + + 90 Yes
Key: + criteria fulfilled; − criteria not fulfilled; MA Methodologically acceptable
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in anticipation of the future economically drain LBP may
place on the individual, the industry and the state [53]. Fu-
ture studies should therefore investigate the factors which
lead to the early onset of LBP among African children and
adolescents and develop prevention strategies which are
effective, feasible and accessible to all people living in rural
and urban areas of Africa.
The findings of this review also clearly show a not-
able difference in point and annual LBP prevalence of
close to 20% between African males and females, with
males reporting a higher prevalence. These results in-
dicate a reverse gender pattern compared to global
trends which generally indicate that females experi-
ence a higher prevalence [92]. What is interesting
CountryPopulation
Algiers
Senegal
South Africa
Mozambique
Tunisia
South Africa
Tunisia
South Africa
South Africa
Nigeria
Nigeria
South Africa
Nigeria
Nigeria
Nigeria
Ethiopia
General population
Public transport 
Nurses
School children
School children
Adolescents
Hospital staff
Steel plant
Manganese plant
Factory workers 
Adolescents
General population
Children/adolescents
University students
Call centre workers
Nurses
Fig. 2 Summary analysis for lifetime prevalence of LBP among African populations
Fig. 3 Subgroup analysis for lifetime prevalence of LBP among African nations (*please note: no subgroup data for Gender:F and Setting:Hospital)
Morris et al. BMC Musculoskeletal Disorders  (2018) 19:196 Page 10 of 15
about this finding is that within most African cul-
tures, African males actually tend to under-report
health issues as it is perceived to reduce their mascu-
linity [93]. A higher prevalence for African females
would therefore have been expected. However, this
said, these findings may also be linked to the fact that
half of the studies on industry included mostly males
or males only, whereas the workers included in the
professional subgroup included more females. Since
industry-related jobs include more intense physical
labour, an over-representation of males may have
therefore resulted.
Fig. 4 Summary analysis of annual prevalence of LBP among African nations
Fig. 5 Subgroup analysis of annual prevalence of LBP among African nations
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Epidemiologic and methodological challenges in
conducting LBP prevalence reviews among African
populations
The review process highlighted a number of challenges
related to conducting, sourcing and pooling relevant epi-
demiologic data in Africa. One of the first methodo-
logical challenges when conducting such a review, was
the uncertainty of whether all relevant data were in-
cluded in the review. This is because a number of
African research studies may not have been published in
journals which are indexed in accessible and commonly-
used international databases [73, 74]. Many African LBP
studies are published in local journals or as a postgradu-
ate thesis, and not all African universities may have in-
formation technology systems which allow online access
to their postgraduate theses [74]. Data may therefore
only be available in the local university libraries. Further-
more, African LBP researchers may not have the
Fig. 6 Summary analysis of point prevalence among African nations
Fig. 7 Subgroup analysis of point prevalence of LBP among African nations
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opportunity to publish in open access journals due to
the associated high publication costs [73–75], which
leads to difficulty in publishing, as well as accessing and
retrieving such publications. The inclusion of all relevant
African literature on LBP prevalence can therefore not
be guaranteed.
Another challenge in conducting this review is the fact
that Africa is riddled by huge economic inequality be-
tween countries. We found that most studies were con-
ducted in Nigeria and South Africa, which have the
strongest economies in Africa and are currently ranked
first and third, respectively in terms of Gross Domestic
Product [75]. In these relatively more affluent countries,
factors such as economic growth and urbanisation have
already followed patterns noted in the developed world
and this could have an effect on LBP occurrence and
reporting [75]. While research fields such as HIV/AIDS
and TB in Africa are well funded by international bodies,
this is not the case with LBP research [3]. LBP research
in poorer African countries is consequently not possible
or encouraged due to prioritisation of research funding
towards other pressing health issues. The economic in-
equality between African countries could therefore have
biased our review findings to more affluent countries.
The poor methodological quality of included studies
posed another challenge in conducting this review since
just over 60% of the studies could be used in the ana-
lyses. Of concern was that most of the shortcomings in
the methods reported by the poor quality studies could
have been avoided. Similarly, to the previous review [10],
and other reviews [2], the poor quality studies in this re-
view generally did not provide a definition of LBP, lacked
adequate representation of the population, did not pro-
vide response rates or drop-out rates, and neglected to
use reliable and/valid instruments (be it a questionnaire,
interview, or examination) for collection of data. Ac-
cording to Dionne et al., it is highly recommended that
epidemiologic studies should at least provide the case
definition used in establishing the prevalence of LBP in a
specified population [76]. In addition, this case definition
for LBP should be standardized to ensure that greater
comparisons between countries (developed or develop-
ing) can be made [76, 77], for a greater understanding of
LBP to be gained [2]. The validity and reliability of
instruments should also be established prior to their ad-
ministration in a specific population to ensure accurate
estimates of prevalence [78]. One important area to
address is the development of a valid and reliable LBP
measurement instrument which should ideally take con-
text and culture into account. Furthermore, improved
collaboration between researchers in different African
countries, will facilitate standardization of measuring
LBP among Africans to assist with comparisons across
countries as well as meta-analytical approaches. It is
therefore recommended that future studies prioritize
conducting studies with improved methodological qual-
ity, provide and use a standardized case definition of
LBP, and report essential information, which will lead to
accurate assessment, interpretation, translation and
comparison of results across studies [79].
Lastly, although measures were taken to ensure that the
heterogeneity among studies was considered during meta-
analyses, the summary estimates provided in this review
should still be viewed with caution [2]. Heterogeneity in
observational studies is however expected [76, 77, 79],
since populations, and even cultural groups within a spe-
cific population, inherently differ [94]. More specifically,
heterogeneity of LBP data remains considerable across
studies due to the lack of a standardized or universal case
definition for LBP [76, 77]. For this reason, the pooling
and comparison of LBP data based on different definitions
is a challenge on its own, regardless of population and
other study characteristic variability [77].
Conclusion
Since the original review was published in 2007, a number
of epidemiologic studies into the prevalence of LBP in
Africa have emerged. This review found that the lifetime,
annual and point prevalence of LBP among African na-
tions, was higher than the global LBP prevalence reported.
Prevention strategies addressing the early onset of LBP
among the youth would most likely be the answer to ad-
dressing the burden of LBP on future economies in Africa.
Caution must however be taken when interpreting the
summary estimates provided in this current review, since
high heterogeneity, which is expected, was displayed
among the included studies. Furthermore, due to the poor
methodological quality found among many of the included
studies, the over-representation of more affluent African
countries and the difficulty in sourcing and retrieving
potential African studies, it is recommended that future
African LBP researchers conduct methodologically robust
studies and report their findings in accessible resources.
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